Molecular markers and staging of early esophageal cancer

Langenbeck's Archives of Surgery

Volumn 388, Issue 2, 2003, Pages 77-82

  Hosch, Stefan B ^a   Stoecklein, Nikolas H ^a   Izbicki, Jakob R ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Early esophageal cancer; Lymphatic micrometastasis; Molecular markers; Molecular staging

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; COMPLEMENTARY DNA; MESSENGER RNA; TUMOR MARKER;

CANCER DIAGNOSIS; CANCER STAGING; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

EID: 0042839666     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-003-0353-y     Document Type: Review

References (44)

1. Lerut T, Coosemans W, Decker G, De Leyn P, Nafteux P, Van Raemdonck D (2001) Cancer of the esophagus and gastro-esophageal junction: potentially curative therapies. Surg Oncol 10:113-122
2. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ (2002) Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347:1662-1669
3. Hagen JA, DeMeester SR, Peters JH, Chandrasoma P, DeMeester TR (2001) Curative resection for esophageal adenocarcinoma: analysis of 100 en bloc esophagectomies. Ann Surg 234:520-530
4. Ormsby AH, Petras RE, Henricks WH, Rice TW, Rybicki LA, Richter JE, Goldblum JR (2002) Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut 51:671-676
5. Reid BJ, Haggitt RC, Rubin CE, Roth G, Surawicz CM, Van Belle G, Lewin K, Weinstein WM, Antonioli DA, Goldman H, et al (1988) Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 19:166-178
6. Meltzer SJ (1996) The molecular biology of esophageal carcinoma. Recent Results Cancer Res 142:1-8
7. Blant SA, Ballini JP, Caron CT, Fontolliet C, Monnier P, Laurini NR (2001) Evolution of DNA ploidy during squamous cell carcinogenesis in the esophagus. Dis Esophagus 14:178-184
8. Galipeau PC, Cowan DS, Sanchez CA, Barrett MT, Emond MJ, Levine DS, Rabinovitch PS, Reid BJ (1996) 17p (p53) allelic losses, 4 N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Proc Natl Acad Sci U S A 93:7081-7084
9. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS (1992) Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 102:1212-1219
10. Robaszkiewicz M, Hardy E, Volant A, Nousbaum JB, Cauvin JM, Calament G, Robert FX, Saleun JP, Gouerou H (1991) [Flow cytometric analysis of cellular DNA content in Barrett's esophagus. A study of 66 cases]. Gastroenterol Clin Biol 15:703-710
11. Teodori L, Gohde W, Persiani M, Ferrario F, Tirindelli Danesi D, Scarpignato C, Di Tondo U, Alo P, Capurso L (1998) DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. Cytometry 34:257-263
12. Reid BJ, Levine DS, Longton G, Blount PL, Rabinovitch PS (2000) Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 95:1669-1676
13. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
14. Lam AK (2000) Molecular biology of esophageal squamous cell carcinoma. Crit Rev Oncol Hematol 33:71-90
15. Mandard AM, Hainaut P, Hollstein M (2000) Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutat Res 462:335-342
16. Jankowski JA, Harrison RF, Perry I, Balkwill F, Tselepis C (2000) Barrett's metaplasia. Lancet 356:2079-2085
17. Wijnhoven BP, Tilanus HW, Dinjens WN (2001) Molecular biology of Barrett's adenocarcinoma. Ann Surg 233:322-337
18. Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, Childs G (1999) Making and reading microarrays. Nat Genet 21:15-19
19. Petricoin EF, Hackett JL, Lesko LJ, Puri RK, Gutman SI, Chumakov K, Woodcock J, Feigal DW, Zoon KC, Sistare FD (2002) Medical applications of microarray technologies: a regulatory science perspective. Nat Genet 32 [Suppl 2]:474-479
20. Selaru FM, Zou T, Xu Y, Shustova V, Yin J, Mori Y, Sato F, Wang S, Olaru A, Shibata D, Greenwald BD, Krasna MJ, Abraham JM, Meltzer SJ (2002) Global gene expression profiling in Barrett's esophagus and esophageal cancer: a comparative analysis using cDNA microarrays. Oncogene 21:475-478
21. Xu Y, Selaru FM, Yin J, Zou TT, Shustova V, Mori Y, Sato F, Liu TC, Olaru A, Wang S, Kimos MC, Perry K, Desai K, Greenwald BD, Krasna MJ, Shibata D, Abraham JM, Meltzer SJ (2002) Artificial neural networks and gene filtering distinguish between global gene expression profiles of Barrett's esophagus and esophageal cancer. Cancer Res 62:3493-3497
22. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JM, Iannettoni MD, Orringer MB, Hanash S (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8:816-824
23. Tachibana M, Dhar DK, Kinugasa S, Yoshimura H, Fujii T, Shibakita M, Ohno S, Ueda S, Kohno H, Nagasue N (2002) Esophageal cancer patients surviving 6 years after esophagectomy. Langenbecks Arch Surg 387:77-83
24. Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM (2002) Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status. Cancer 95:1434-1443
25. Gusterson B, Ott R (1990) Occult axillary lymph-node micrometastases in breast cancer. Lancet 336:434-435
26. Pantel K, Cote RJ, Fodstad O (1999) Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91:1113-1124
27. Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, Pantel K (1997) Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 337:1188-1194
28. Vazquez-Sequeiros E, Wang L, Burgart L, Harmsen W, Zinsmeister A, Allen M, Jondal M, Wiersema M (2002) Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma. Gastroenterology 122:1815-1821
29. Matsumoto M, Natsugoe S, Nakashima S, Sakamoto F, Okumura H, Sakita H, Baba M, Takao S, Aikou T (2000) Clinical significance of lymph node micrometastasis of pN0 esophageal squamous cell carcinoma. Cancer Lett 153:189-197
30. Natsugoe S, Mueller J, Stein HJ, Feith M, Hofler H, Siewert JR (1998) Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis. Cancer 83:858-866
31. Sato F, Shimada Y, Li Z, Watanabe G, Maeda M, Imamura M (2001) Lymph node micrometastasis and prognosis in patients with oesophageal squamous cell carcinoma. Br J Surg 88:426-432
32. Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Takasaki K (2002) Clinical implications of lymph node micrometastasis in patients with histologically node-negative (pN0) esophageal carcinoma. J Surg Oncol 79:224-229
33. Pantel K, Braun S, Passlick B, Schlimok G (1996) Minimal residual epithelial cancer: diagnostic approaches and prognostic relevance. Progress in histochemistry and cytochemistry. Fischer, Stuttgart
34. Passlick B, Izbicki JR, Kubuschok B, Nathrath W, Thetter O, Pichlmeier U, Schweiberer L, Riethmuller G, Pantel K (1994) Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol 12:1827-1832
35. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H (1990) Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial. J Clin Pathol 43:213-219
36. Gottlinger HG, Funke I, Johnson JP, Gokel JM, Riethmuller G (1986) The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies. Int J Cancer 38:47-53
37. Hosch SB, Stoecklein NH, Pichlmeier U, Rehders A, Scheunemann P, Niendorf A, Knoefel WT, Izbicki JR (2001) Esophageal cancer: the mode of lymphatic tumor cell spread and its prognostic significance. J Clin Oncol 19:1970-1975
38. Kubuschok B, Passlick B, Izbicki JR, Thetter O, Pantel K (1999) Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer. J Clin Oncol 17:19-24
39. Hosch SB, Knoefet WT, Metz S, Stoecklein N, Niendorf A, Broelsch CE, Izbicki JR (1997) Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 15:154-159
40. Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH, Riethmuller G (2002) Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360:683-689
41. Traweek ST, Liu J, Battifora H (1993) Keratin gene expression in non-epithelial tissues. Detection with polymerase chain reaction. Am J Pathol 142:1111-1118
42. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H, Akiyoshi T (1995) Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 55:3417-3420
43. Godfrey TE, Raja S, Finkelstein SD, Gooding WE, Kelly LA, Luketich JD (2001) Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients. Clin Cancer Res 7:4041-4048
44. Raja S, Luketich JD, Kelly LA, Gooding WE, Finkelstein SD, Godfrey TE (2002) Rapid, quantitative reverse transcriptase-polymerase chain reaction: application to intraoperative molecular detection of occult metastases in esophageal cancer. J Thorac Cardiovasc Surg 123:475-482